Skip to content.

Appili Therapeutics announces closing of public offering of C$7M

Date Closed

October 14, 2021

Lead Office

Québec City


7.00 Million CAD

On October 14, 2021, Appili Therapeutics Inc. announced the closing of its previously announced public offering of units. The Offering was made pursuant to an agency agreement entered into with a syndicate of agents led by Bloom Burton Securities Inc. and including iA Private Wealth Inc., Leede Jones Gable Inc., Research Capital Corporation, and Richardson Wealth Limited and Appili Therapeutics Inc..

Pursuant to the Offering, Appili Therapeutics Inc. issued a total of 8,434,000 units at a price of $0.83 per unit for aggregate gross proceeds of C$7,000,220. Each unit is comprised of one Class A common share of Appili Therapeutics Inc.(Common Share) and one-half of one Common Share purchase warrant of Appili Therapeutics Inc.  Each Warrant entitles the holder thereof to acquire one Common Share at an exercise price of $1.10 per Warrant Share until October 14, 2024.

McCarthy Tétrault advised the syndicate of agents with a team led by Philippe Leclerc that included Mireille Trottier (Business).